Intellia Therapeutics: Pay

Intellia Therapeutics paid its 5 named executives $12.8M in total in FY2025 (Dec). CEO John M. Leonard, M.D. was paid $5.1M of that.

Pay$100 in the stock at the end of FY20 → $17
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

John M. Leonard, M.D.President, Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Edward J. Dulac IIIExecutive Vice President, Chief Financial
FY2025 (Dec)
FY2024 (Dec)
2 years
David Lebwohl, M.D.Executive Vice President, Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
James Basta, J.D.Executive Vice President, General Counsel and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Birgit Schultes, Ph.D.Executive Vice President, Chief Scientific Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 10 peers with pay on file was $8.7M. The CEO of Intellia Therapeutics was paid $5.1M, 42% below the median.

  1. 1Madrigal Pharmaceuticals
  2. 2BridgeBio Pharma
  3. 3ImmunityBio
  4. 4Immunovant
  5. 5IDEAYA Biosciences
  6. 6Vir Biotechnology
  7. 7CRISPR Therapeutics AG
  8. 8Beam Therapeutics
  9. 9Intellia Therapeutics
  10. 10Denali Therapeutics
  11. 11Relay Therapeutics
  12. 12Allogene Therapeutics, Inc.Not disclosed
  13. 13Arrowhead PharmaceuticalsNot disclosed
  14. 14Editas Medicine, Inc.Not disclosed
  15. 15Iovance BiotherapeuticsNot disclosed
  16. 16Prime Medicine, Inc.Not disclosed
  17. 17Rocket Pharmaceuticals, Inc.Not disclosed
  18. 18Sana Biotechnology, Inc.Not disclosed
  19. 19VaxcyteNot disclosed
  20. 20Verve Therapeutics, Inc.Not disclosed
  21. 21XencorNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.